GoodRx Holdings Inc. (GDRX) experienced a notable increase in its stock price following the introduction of a groundbreaking subscription service aimed at treating erectile dysfunction. Priced competitively at $18 per month, the service not only provides online consultations but also ensures discreet delivery to alleviate common concerns like high costs and social stigma, which often deter men from seeking necessary treatment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.